Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Nov 27;71(10):2581–2588. doi: 10.1093/cid/ciz1149

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 3. — Treatment differences between fidaxomicin and vancomycin for rates of confirmed clinical response, recurrence, and global cure (full analysis set). ^aAdjusted treatment difference (calculated using age-stratified Cochran-Mantel-Haenszel test, for which 95% confidence intervals [CIs] were calculated using a Newcombe method). ^bUnadjusted treatment differences (with exact 95% CIs calculated using a binomial distribution). ^cAdjusted difference not estimable. Abbreviations: CI, confidence interval; EOS, end of study; EOT, end of treatment.